138
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Primary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic characterization and assessment of switching to tocilizumab

&
Pages 628-636 | Received 18 Jan 2011, Accepted 13 Apr 2011, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (5)

Lisa Baganz, Adrian Richter, Jörn Kekow, Arnold Bussmann, Andreas Krause, Carsten Stille, Joachim Listing, Angela Zink & Anja Strangfeld. (2017) Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort. Rheumatology International 38:4, pages 579-587.
Crossref
Ahmad H. Alghadir, Sami A. Gabr & Einas S. Al-Eisa. (2016) Green tea and exercise interventions as nondrug remedies in geriatric patients with rheumatoid arthritis. Journal of Physical Therapy Science 28:10, pages 2820-2829.
Crossref
Pier Luigi Meroni, Gabriele Valentini, Fabio Ayala, Antonino Cattaneo & Guido Valesini. (2015) New strategies to address the pharmacodynamics and pharmacokinetics of tumor necrosis factor (TNF) inhibitors: A systematic analysis. Autoimmunity Reviews 14:9, pages 812-829.
Crossref
Konstantinos Papamichael, Ann Gils, Paul Rutgeerts, Barrett G. Levesque, Séverine Vermeire, William J. Sandborn & Niels Vande Casteele. (2015) Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD. Inflammatory Bowel Diseases 21:1, pages 182-197.
Crossref
Maarten L. Zandvliet, Jine S. van Bezooijen, Mariska A. Bos, Errol P. Prens, Martijn van Doorn, Ilona Bijen, Marco W. J. Schreurs, Vincent H. J. van der Velden, Birgit C. P. Koch & Teun van Gelder. (2013) Monitoring Antigen-Specific Biologics. Therapeutic Drug Monitoring 35:5, pages 588-594.
Crossref